Tagged with MS

Cyprus Sotos Jacovides is managing the company M.S. Jacovides & Co. Ltd alongside his three brothers, Aris, Alex and Savvas, to continue on the legacy of their father. Now strongly established as one of the leading healthcare companies in Cyprus, M.S. Jacovides is looking forward to entering new and promising niches…

UK One notable quirk of the British life sciences ecosystem is the importance of its not-for-profit sector. Indeed, in 2017, UK charities poured GBP 1.6 billion (USD 2.1 billion) into medical research; more than both the Medical Research Council (MRC) and the National Institute for Health Research (NIHR). Simon Gillespie, chief…

Spain Angel Fernandez, president and managing director of MSD Spain and Portugal, covers the company´s current pipeline and portfolio strategy. He also explains how the company collaborate with a wide variety of stakeholders.   What is the history of MSD in the Spanish market? Overall, MSD is a company with 127…

Cyprus   Jacqueline Anastassiades has been involved in the development of the Cypriot healthcare sector for more than 10 years as the Managing Director of MSD. With the upcoming healthcare reforms, she brings her expert insights into the key requirements the Cyprus national health system should validate as well as the…

UK Having just announced a major investment into a new UK Discovery Centre in London that is set to open in 2020, MSD is committed to leverage on the UK’s potential in driving forward early stage discovery. Louise Houson, Managing Director for the UK and Ireland explains the reasons for that…

Portugal The top 20 pharma companies in Portugal ranked by sales and market share for the year leading up to March 2018. MSD leads the way with EUR 148 million in sales and a 5.4 percent market share, followed by Mylan and Bayer.

China Dr. Chen Hao is the CEO and founder of the promising startup Imsight, the only company focusing on medical imaging analysis using Artificial Intelligence technology in the Greater Bay Area. In this exclusive interview, the young and ambitious entrepreneur explains how Imsight’s research-driven solutions will revolutionize the relationship between doctors…

Portugal Henrique Manuel Gil Martins, chairman of SPMS (Shared services of the Ministry of Health) provides an insight into the uptake of technology in Portugal’s Ministry of Health and National Health Service (NHS). Furthermore, he describes the importance of becoming more technologically aware as it reduces costs and makes health activities…

UK Sir Robert Lechler, president of the Academy of Medical Sciences (AMS), discusses the Academy’s role in promoting medical research in the UK and how that stands to change in the wake of the country’s decision to leave the European Union. What role does the AMS play in the UK? “We…

India Yugal Sikri, chairman of the Pharmaceutical Management Program of the prestigious NMIMS University, and with an extremely rich experience in the pharmaceutical industry, explains his mission to build a valuable discussion platform for CEOs and institutions of the industry alike.  Such industry efforts will ensure the Indian pharmaceutical industry efficiently…

UK Michelle Mitchell, CEO of the Multiple Sclerosis Society in the UK since 2013, discusses her charity’s aims; their focus on research and development; funding in the face of Brexit; and policy changes in the future.   Although the MS community is fairly small, the science is telling us that with…

India A strong supporter of public-private partnerships, MSD’s managing director in India, Vivek Kamath, explains how the company’s collaborative approach is the key to enhancing their reputation, improving patient outcomes and tackling unmet medical needs in India.   Mr. Kamath, you have worked for MSD for over four years and you…